![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Perry Rosenthal (September 2, 1933 - March 3, 2018), was a Canadian-born American eye surgeon and professor of ophthalmology, known for his work in the development of the first gas-permeable scleral contact lens. [1] [2]
Following his graduation from McGill University Medical School in May 1958, Rosenthal completed his internship at Montreal General Hospital in 1959. [3] From 1959 until April 1960, he completed a basic science course in ophthalmology at Harvard Medical School, Boston, Massachusetts. He was a resident in ophthalmology at the Massachusetts Eye and Ear Infirmary from 1960 to 1963, then joined the infirmary staff. [4] From 1963 to 1998, he was in private practice, and a staff surgeon at the Massachusetts Eye and Ear Infirmary. He was then named to the infirmary's courtesy staff, and, since 2013, was an emeritus member. [5] Rosenthal was a part-time Assistant Clinical Professor in Ophthalmology at Harvard Medical School since 1984. [6]
As a resident at Massachusetts Eye and Ear Infirmary, Rosenthal founded the hospital's contact lens clinic. [4] He subsequently became a co-founder of Polymer Technology Inc., which developed Boston Lens products, including a rigid gas-permeable plastic that allowed the corneas to breathe normally through the contact lenses. The firm was subsequently acquired by Bausch & Lomb, of which Rosenthal became a director. In 1986, he developed a practical, gas-permeable scleral contact lens to treat and restore vision of eyes with many corneal diseases, which ave been widely adopted in clinical practice, [7] [8] He has also published on oculofacial pain, [9] [10] and dry-eye disease. [11] [12]
In 1992, he created the non-profit Boston Foundation for Sight to provide these devices to those in need, regardless of their ability to pay. [13] [14] He remained president until 2012. [15] [16] In 2013, he founded the non-profit Boston EyePain Foundation, in Chestnut Hill, Massachusetts. [17]
His most cited publications are:
{{
citation}}
: Missing or empty |url=
(
help)
![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Perry Rosenthal (September 2, 1933 - March 3, 2018), was a Canadian-born American eye surgeon and professor of ophthalmology, known for his work in the development of the first gas-permeable scleral contact lens. [1] [2]
Following his graduation from McGill University Medical School in May 1958, Rosenthal completed his internship at Montreal General Hospital in 1959. [3] From 1959 until April 1960, he completed a basic science course in ophthalmology at Harvard Medical School, Boston, Massachusetts. He was a resident in ophthalmology at the Massachusetts Eye and Ear Infirmary from 1960 to 1963, then joined the infirmary staff. [4] From 1963 to 1998, he was in private practice, and a staff surgeon at the Massachusetts Eye and Ear Infirmary. He was then named to the infirmary's courtesy staff, and, since 2013, was an emeritus member. [5] Rosenthal was a part-time Assistant Clinical Professor in Ophthalmology at Harvard Medical School since 1984. [6]
As a resident at Massachusetts Eye and Ear Infirmary, Rosenthal founded the hospital's contact lens clinic. [4] He subsequently became a co-founder of Polymer Technology Inc., which developed Boston Lens products, including a rigid gas-permeable plastic that allowed the corneas to breathe normally through the contact lenses. The firm was subsequently acquired by Bausch & Lomb, of which Rosenthal became a director. In 1986, he developed a practical, gas-permeable scleral contact lens to treat and restore vision of eyes with many corneal diseases, which ave been widely adopted in clinical practice, [7] [8] He has also published on oculofacial pain, [9] [10] and dry-eye disease. [11] [12]
In 1992, he created the non-profit Boston Foundation for Sight to provide these devices to those in need, regardless of their ability to pay. [13] [14] He remained president until 2012. [15] [16] In 2013, he founded the non-profit Boston EyePain Foundation, in Chestnut Hill, Massachusetts. [17]
His most cited publications are:
{{
citation}}
: Missing or empty |url=
(
help)